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A b s t r a c t
Background: Patients with advanced lower limb ischaemia are, at present, mainly treated using revascularisation. 
Aim: The aim of the study was to investigate whether the dynamics of blood flow in below-the-knee (BTK) arteries assessed 
by angiography correlate with clinical outcomes after a 12-month follow-up in patients with severe leg ischaemia treated per-
cutaneously.
Methods: The current study enrolled 287 consecutive patients who underwent 302 endovascular procedures on the infrain-
guinal arteries. The mean age of the included participants was 67.4 ± 10.4 years. After the procedure, blood flow in all patent 
BTK arteries was assessed using frame count (FC). Patients were then evaluated after one, three, six, and 12 months. During 
the follow-up visits, clinical condition was evaluated based on the Rutherford scale, ankle-brachial index, and the need for 
reintervention or amputation.
Results: Clinical improvement at the end of the follow-up period was observed in 242 (80.1%) cases and no improvement 
or worsening in was seen in 42 (13.0%) patients. In total, 66 (21.8%) reinterventions and 18 (6%) amputations during the 
follow-up period were recorded. Patients with higher FC in the tibial anterior artery experienced significantly better clinical 
improvement within the 12-month follow-up period (p = 0.02). Lower FC predisposed to worse clinical outcomes after an-
gioplasty. Similar tendencies were found for the tibial posterior and fibular arteries but without statistical significance. 
Conclusions: The results suggest a negative relationship between FC observed on the final angiogram and clinical outcomes 
in patients undergoing endovascular treatment of the peripheral arteries. 
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INTRODUCTION
Patients with advanced lower limb ischaemia are, at present, 
mainly treated using revascularisation. While percutaneous 
treatment is becoming increasingly popular due to lower 
periprocedural risks compared with open vascular surgery, 
it seems that the long-term outcomes of any type of revas-
cularisation are far from optimal [1]. Recently, significant 
improvement of devices used for endovascular treatment 
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and techniques of revascularisation have been introduced. 
The development of a system that would be able to predict 
clinical outcomes in patients with peripheral arterial disease 
(PAD), such as amputation-free survival or overall survival, 
could help clinicians in decision-making and guiding the ap-
propriate usage of health care resources. To date, a number 
of studies have been published demonstrating predictors of 
clinical outcome in patients after percutaneous transluminal 
angioplasty (PTA) of the infrainguinal arteries [2, 3]. Among 
others, biochemical indices such as the urinary leukotriene 
E4 or thromboxane were found to be associated with 
long-term results [4]. Apart from biomarkers and clinical 
scoring systems, clinical outcomes could also be predicted 
based on angiographic findings, including the runoff grade [5], 
which was designed to evaluate treatment results after bypass 
surgery. Despite its subjective form, it was proven to predict 
clinical outcome [6, 7]. There are scoring systems used in 
cardiology that can predict clinical outcomes in patients who 
have undergone percutaneous coronary interventions. The 
Thrombolysis In Myocardial Infarction (TIMI) flow grade and 
the corrected TIMI frame count (FC) are among the most 
commonly used methods. Despite their subjectivity, they are 
simple, easy-to-use, and time-effective tools to assess the 
dynamics of blood flow in the epicardial coronary arteries 
[8, 9]. However, the currently used scoring systems are not 
sufficient, and there is still a need to create more objective 
ones dedicated to the peripheral vessels, which could predict 
immediate and long-term clinical outcomes. 
Therefore, the aim of the current study was to investigate 
whether the dynamics of blood flow in below-the-knee (BTK) 
arteries assessed by angiography are associated with clinical 
outcome during a 12-month follow-up among patients with 
severe leg ischaemia treated percutaneously.
METHODS
Study population, design, and definitions 
The current study enrolled 287 consecutive patients who 
underwent 302 endovascular treatments on the infrainguinal 
arteries at a large angiology centre. The patient recruitment 
lasted from March until October 2015. The mean age of the 
included participants was 67.4 ± 10.4 years (Table 1). There 
were 162 procedures performed in critical limb ischaemia 
(CLI) patients and 140 procedures in patients with limb clau-
dication (non-CLI patients) (Table 2). After the procedure, 
blood flow in all patent BTK arteries was assessed using the 
FC evaluation method adapted to the purposes of the present 
study. Patients were then evaluated after one, three, six, and 
12 months. During the follow-up visits, clinical condition was 
assessed based on the Rutherford scale, ankle-brachial index 
(ABI), as well as reintervention and amputation rates. Medi-
cal therapy after percutaneous interventions was continued 
according to the current recommendations. Chronic kidney 
disease was defined as impaired kidney function expressed 
as decreased glomerular filtration rate (< 60 mL/min/1.73 m2) 
for three months or more, irrespective of the cause, estimated 
using the Cockcroft-Gault formula. Hypercholesterolaemia, 
hypertension, diabetes, coronary artery disease, and heart 
failure were defined according to the European Society of 
Cardiology guidelines and previous diagnoses from prior hos-
pital discharge cards [10–14]. Other diagnoses were taken into 
account on the basis of the information found on prior hospital 
discharge cards. The study complies with the Declaration of 
Helsinki. All subjects provided written and informed consent 
for participation prior to enrolment.
Frame count
Blood flow rate in the BTK arteries was assessed by means of 
digital subtraction angiography using the Integris V 3000 angio-
graphy unit (Philips, Eindhoven, Netherlands). Patients were 
examined in a supine position. The source-to-image distance 
was kept at a constant of 100 cm. A 31-cm field of view 
diameter was used, and the image intensifier was positioned 
against the calf of the patient. The intensifier was positioned in 
such a way that the maximal length of the calf was visualised, 
with intercondylar prominence of the tibia maintained at the 
uppermost point of the image. The contrast medium (Ultravist 
370, Schering Pharma AG, Berlin, Germany) was manually 
injected into the sheath positioned into the ipsilateral common 
femoral artery. Images were recorded at a rate of six frames 
per second. The number of frames between the first arrival of 
the contrast at the proximal part of the image and its reach-
ing the most distal part of each of the axial calf arteries, i.e. 
the tibial arteries, and the fibular artery (FA), was measured 
for each of the vessels and used for further analysis. The 
first frame was defined as the one in which the contrast dye 
fully entered the artery, fulfilling all of the following criteria: 
a) a column of fully concentrated dye had to be extended across 
the entire width of the origin of the artery, b) the dye had to 
touch both borders of the origin of the artery, and c) there 
had to be antegrade motion of the dye. The last frame was 
defined as the one in which the dye first entered the artery 
at the distal edge of the image. Full opacification of the artery 
was not required. Often, the final frame is best determined 
by running the cine film past the initial opacification of the 
end-point branch and then moving frame-by-frame in reverse 
until the endpoint branch disappears [9]. We did not correct 
the BTK FC for the length of the arteries because the purpose 
of the study was to assess the blood flow velocity in the BTK 
arteries, regardless of the length of the vessels that supply 
blood to them, and consequently, the height and surface 
area of the patients.
Statistical analysis
The schedule frequency characteristics were measured on 
a nominal or ordinal scale and, for continuous variables, 
by using descriptive statistics including arithmetic mean 
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and standard deviation or median and interquartile range, 
where applicable. Normal distribution was checked with the 
Shapiro-Wilk test. Student t-test or the Mann-Whitney U test 
was used when applicable for the comparison of continuous 
variables, while the c2 test was applied for categorical vari-
ables. ANOVA analysis was used to assess trend significance 
at consecutive follow-up visits. A model based on the retro-
grade correction method was constructed for the purpose 
of performing a multivariate analysis. The model included 
anthropometric indices, concomitant diseases, smoking 
status, age, sex, kidney function parameters, clinical presen-
tation of PAD at baseline, location of the culprit artery and 
PTA, number of occluded arteries, ABI, and Rutherford class 
at baseline. Receiver operator characteristic (ROC) curve 
analysis was performed to determine optimal cut-off values 
when the sensitivity approximates specificity, as well as their 
relationship between TIMI FC and study endpoints. A p-value 
of < 0.05 was considered statistically significant. Due to the 
fact that the results of the current study were not a primary 
outcome, we did not calculate the power of the study. 
However, in a power analysis performed after the study for 
the alpha coefficient of 2.5% and almost 100 patients with 
a composite study endpoint and 200 patients without it, the 
power was calculated at 80%, which is a standard result and 
should be sufficient to determine the relationships between 
particular factors in the two groups. Statistical analyses were 
performed using Statistica 10.0 software (Dell Software, 
Inc., Round Rock, TX, USA) and SPSS STATISTICS 24 (IBM, 
Armonk, NY, USA). 
RESULTS
Clinical characteristics of all participants (Table 1), character-
istics of the PTA procedures, including lesion location and 
type (stenosis vs. occlusion), number of occluded BTK and 
pedal arteries, as well as the FC (Table 2) showed differences 
between the CLI and non-CLI patients. Clinical improvement 
at the end of the follow-up period was observed in a total of 
242 (80.1%) cases, and no improvement or worsening was 
seen in 42 (13.0%) cases (Figs. 1, 2). Altogether, 66 (21.8%) 
reinterventions and 18 (6%) amputations were recorded dur-
ing the follow-up period (Table 3). In the group of patients 
that required reinterventions, 40 (60.6%) cases improved 
clinically, 13 (19.7%) presented stable clinical symptoms, three 
(4.5%) patients worsened clinically, and 10 (15.5%) underwent 
amputation. In the group of patients without reinterventions 
(236 procedures; 78.1%) clinical improvement was noted in 
202 (85.6%) cases, no improvement in 25 (10.6%), worsening 
in one (0.4%), and amputation in eight (3.4%). The endpoint 
was observed in a lower number of patients (n = 16): three 
patients died during the follow-up period and 13 were lost 
to follow-up due to unspecified reasons. While assessing the 
distribution of FC in particular BTK arteries, most patients 
represented the groups with FC lower than six, between five 
and 10, and between 10 and 20 (Fig. 2). 
Dynamics of blood flow
The dynamics of blood flow were assessed in the anterior 
tibial artery (ATA), posterior tibial artery (TPA), and FA. Higher 
FC (slower blood flow) was found in younger patients (ATA: 
Table 1. General characteristics of the patients
Overall group 
(n = 302)
CLI  
(n = 162)
Non-CLI  
(n = 140)
p
Male/female sex 180/122 90/72 92/48 0.07
Age [years] 67.4 ± 10.4 69.4 ± 10.2 65.0 ± 10.1 < 0.001
Current smokers 52 (17.2) 29 (17.9) 23 (16.4) 0.69
Former smokers 119 (39.4) 56 (34.5) 63 (45) 0.07
Prior cerebral stroke/TIA 32 (10.6) 21 (13.0) 11 (7.8) 0.14
Glomerular filtration rate [mL/min/m2] 72.3 ± 24.3 69.4 ± 25.7  75.7 ± 22.1 0.02
Kidney failure 39 (12.9) 26 (16.0) 13 (9.3) 0.07
Dialysis therapy 6 (1.9) 5 (3.1) 1 (0.7) 0.13
Heart failure 25 (8.3) 19 (11.7) 6 (4.3) 0.01
Coronary artery disease 142 (47.0) 77 (47.5) 65 (46.4) 0.76
Prior myocardial infarction 56 (18.5) 31 (19.1) 25 (17.8) 0.73
Hypertension 232 (76.8) 124 (76.5) 108 (77.1) 0.94
Diabetes 143 (47.3) 92 (56.8) 51 (36.4) < 0.001
Insulin therapy 96 (31.8) 67 (41.3) 29 (20.7) < 0.001
Hypercholesterolaemia 85 (28.1) 48 (29.6) 37 (26.4) 0.49
Data are presented as arithmetic mean ± standard deviation or number (percentage). CLI — critical limb ischaemia; TIA — transient ischaemic attack
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p = 0.052, r = –0.13; FA: p = 0.02, r = –0.15) and in those 
with less advanced clinical symptoms, i.e. lower Rutherford 
class (ATA: p < 0.001, r = –0.28; TPA: p = 0.001, r = –0.21; 
FA: p < 0.001, r = –0.38). Similar observations were made 
for patients with less advanced angiological findings such as 
lower Trans-Atlantic Inter-Society Consensus Document on 
Management of Peripheral Arterial Disease (TASC) grade (ATA: 
p = 0.01, r = –0.16; TPA: p = 0.01, r = –0.2; FA: p = 0.01, 
r = –0.16) and a larger number of patent BTK vessels (ATA: 
p = 0.01, r = –0.17; FA: p < 0.0001, r = –0.28). We found 
that FC was higher in non-CLI patients (ATA: p < 0.0001, 
r = –0.26; TPA: p = 0.009, r = –0.21; FA: p < 0.0001, 
r = –0.37), those who underwent treatment of the super-
ficial femoral artery in comparison to other locations (ATA: 
p = 0.03, r = 0.14), and in patients with higher mean ABI 
value (TPA: p = 0.001, r = 0.25). This trend was similar when 
the groups of patients with CLI and those with claudication 
were analysed separately. The relationship between the level 
of PTA, clinical study endpoints, and FC according to particular 
BTK arteries is presented in Table 4. 
Frame count and clinical outcomes
Patients with higher FC (slower blood flow) in ATA had a sig-
nificantly greater clinical improvement (based on the Ruther-
ford scale) during the 12-month follow-up period (p = 0.02). 
Lower FC (faster blood flow) predisposed to worse clinical 
Table 2. Atherosclerotic lesion characteristics and frame count
Overall group 
(n = 302)
CLI  
(n = 162)
Non-CLI  
(n = 140)
p
Level of PTA:
Superficial femoral artery 215 (71.2) 97 (59.9) 118 (84.3) < 0.001
Popliteal artery 130 (43.0) 78 (48.1) 52 (37.1) 0.054
BTK artery 148 (49.0) 112 (69.1) 36 (25.7) < 0.001
Occluded BTK arteries: 
None 55 (18.2) 24 (14.8) 31 (22.1) 0.09
One 158 (52.3) 78 (48.1) 80 (57.1) 0.0004
Two 89 (29.4) 60 (37.0) 29 (20.7) 0.002
Lesion type before PTA: 
Stenosis 114 (37.7) 48 (29.6) 66 (47.1) 0.0017
Occlusion 188 (62.2) 114 (70.4) 74 (52.8) 0.0017
Occluded foot arteries: 
None 89 (29.5) 40 (24.7) 49 (35) 0.05
One 142 (47.0) 77 (47.5) 65 (46.4) 0.84
Two 71 (23.5) 45 (27.8) 26 (18.6) 0.059
TASC classification: 
0 42 (13.9) 36 (22.2) 6 (4.3) 0.039
A 37 (12.2) 14 (8.6) 23 (16.4) < 0.001
B 76 (25.1) 20 (12.3) 56 (40) < 0.001
C 64 (21.2) 33 (20.4) 31 (22.1) 0.7
D 83 (27.5) 59 (34.4) 24 (17.1) 0.0002
Frame count (frames per artery):
Anterior tibial artery 11.3 ± 12.1 8.0 ± 7.7 14.4 ± 14.4 < 0.001
8 (5 ÷ 12,7) 6 (4 ÷ 9) 11 (6 ÷ 17)
Tibial posterior artery 11.3 ± 10.0 9.1 ± 7.8 13.4 ± 11.3 0.009
8 (5 ÷ 15) 6 (4.2 ÷ 10) 10 (5.5 ÷ 17)
Fibular artery 11.7 ± 8.3 8.8 ± 4.9 15.1 ± 10.0 < 0.001
9 (6 ÷ 14.2) 7 (6 ÷ 11) 12 (8 ÷ 20)
Data are presented as arithmetic mean ± standard deviation, median ÷ interquartile range, or number (percentage). BTK — below-the-knee;  
CLI — critical limb ischaemia; PTA — percutaneous transluminal angioplasty; TASC — Trans-Atlantic Inter-Society Consensus Document on  
Management of Peripheral Arterial Disease
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outcomes after PTA (Fig. 3A). Similar tendencies were found 
for TPA and FA but without statistical significance. 
Frame count and ankle-brachial index
We found no relationship between FC in particular BTK arter-
ies and ABI (calculated as changes in ABI values measured 
directly before and after the procedure, as well as the ABI 
value after 12 months of follow-up and at baseline). There 
was a significant improvement of ABI values after PTA at 
consecutive follow-up visits (p < 0.001) (Fig. 1A). 
Study endpoints
The overview of the clinical study endpoints is presented in 
Tables 3 and 4.
Amputations
We found no relationship between the FC in the BTK arter-
ies (ATA, TPA, and FA) and the number of amputations. The 
amputation rate during the follow-up period was almost 
two times greater in patients with occluded ATA after PTA 
compared to those with patent ATA, but without statistical 
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Figure 1. A. Mean values of the ankle-brachial index (ABI) at consecutive follow-up visits; B. Mean values of the Rutherford class 
at consecutive follow-up visits; CLI — critical limb ischaemia; M — months
Figure 2. Quantitative distribution of the number of patients depending on frame count range; ATA — anterior tibial artery;  
CLI — critical limb ischaemia; FA — fibular artery; TPA — posterior tibial artery
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Table 3. Study endpoints after 12 months of follow-up
Overall group 
(n = 302)
CLI  
(n = 162)
Non-CLI  
(n = 140)
p
Reinterventions 66 (21.8) 46 (28.4) 20 (14.3) 0.003
Amputations 18 (6.0) 17 (10.5) 1 (0.7) < 0.001
No clinical improvement 60 (19.9) 35 (21.6) 25 (17.8) 0.41
Composite study endpoint 98 (32.4) 61 (37.6) 37 (26.4) 0.03
Data are presented as number (percentage). No clinical improvement means that after 12 months of follow-up, the Rutherford class was the same 
or worse than before percutaneous transluminal angioplasty, with the inclusion of patients with amputation. CLI — critical limb ischaemia
Table 4. Study endpoints after 12 months of follow-up and frame count according to the location of the treated lesion
Superficial femoral 
artery (n = 215)
Popliteal artery 
(n = 130)
Below-the-knee 
artery (n = 148)
p
Reinterventions 43 (20) 35 (26.9) 42 (28.4) 0.13
Amputations 7 (3.2) 8 (6.1) 17 (11.5) 0.007
No clinical improvement 34 (15.8) 33 (25.4) 40 (27) 0.02
Composite study end-point 63 (29.3) 52 (40) 60 (40.5) 0.04
Frame count (frames per artery):
Anterior tibial artery 12.5 ± 13.7 8.1 ± 5.8 9.5 ± 8.9 0.002
8 (5 ÷ 14.7) 6 (4 ÷ 10) 7 (4 ÷ 10)
Tibial posterior artery 11.9 ± 10.4 8.7 ± 6.6 9.9 ± 7.9 0.051
9 (5 ÷ 15.7) 6 (5 ÷ 10) 7 (5 ÷ 12)
Fibular artery 12.3 ± 8.8 9.2 ± 5.8 10.5 ± 7.3 0.06
9.5 (6 ÷ 17) 7 (5 ÷ 11) 8 (6 ÷ 12)
Data are presented as arithmetic mean ± standard deviation, median ÷ interquartile range, or number (percentage). No clinical improvement  
means that after 12 months of follow-up, the Rutherford class was the same or worse than before percutaneous transluminal angioplasty, with the 
inclusion of patients with amputation; clinical improvement means that after 12 months of follow-up, the Rutherford class has improved (decreased).
Figure 3. A. The relationship between frame count in anterior tibial artery (ATA) and clinical outcomes in patients with clinical 
improvement and stable clinical symptoms during the follow-up period vs. individuals with worse clinical symptoms, reinterven-
tions, and amputations; B. The relationship between frame count in ATA and reinterventions in patients with clinical improve-
ment and stable clinical symptoms during the follow-up period vs. individuals with worse clinical symptoms, reinterventions,  
and amputations
BA
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significance (8.33% vs. 4.85%, p = 0.23). There were no cor-
relations between the ATA, TPA, and FA. The amputation rate 
in patients with at least two occluded BTK arteries was higher 
compared to those in whom one artery was occluded or those 
without occlusion, but not significantly (7.78% vs. 5.66% and 
3.77%, p = 0.6). The amputation rate was more than twofold 
higher in patients with occluded BTK arteries undergoing PTA 
compared to those with stenosed arteries, but without statisti-
cal significance (7.45% vs. 3.51%, p = 0.16). 
Reinterventions
The amputation rate was higher among patients requiring re-
interventions during the follow-up period compared to others 
(15.1% vs. 3.3%, p < 0.001). Patients with lower FC in ATA 
presented higher reintervention rates during the follow-up 
period (11.8 ± 12.4 vs. 9.4 ± 10.6 frames, p = 0.02; Fig. 3B). 
This relationship was not significant for TPA or FA. Occlusion 
of ATA, TPA, and FA after PTA was not related to a higher 
reintervention rate during the follow-up period. The percent-
age of reinterventions was not connected with the number of 
occluded arteries or the lesion type. 
CLI vs. non-CLI patients
Patients with CLI were associated with a significantly lower 
number of FCs (faster blood flow) when compared to clau-
dicants. Patients who improved or had stable symptoms 
after PTA within the 12 months of follow-up, those initially 
non-CLI, achieved better clinical outcomes (p = 0.005). The 
amputation rate during the 12-month follow-up period was 
significantly higher in CLI patients. Based on the Rutherford 
scale (Rutherford class from 2 to 6), the amputation rates were 
0%, 0.7%, 2.1%, 11.8%, and 26.6%, respectively (p < 0.001). 
Similarly, the reintervention rate was the highest in CLI patients 
compared to non-CLI ones (p = 0.03). 
Multivariate and ROC analysis
Multivariate analysis revealed that PTA performed on the 
popliteal artery was an independent predictor of better clinical 
outcome after 12 months of follow-up, expressed as a combi-
nation of amputation rate and lack of clinical improvement, 
in comparison to PTA of other infrainguinal arteries (hazard 
ratio [HR] = 0.46; 95% confidence interval [CI] 0.23–0.89; 
p = 0.02), while PTA of the BTK arteries was an independ-
ent predictor of increased amputation (HR = 7.4; 95% CI 
2.1–25.6; p = 0.002) and reintervention rates (HR = 2.1; 
95% CI 1.2–3.7; p = 0.008). In comparison to other locations, 
PTA of the popliteal (HR = 1.8; 95% CI 1.1–2.9; p = 0.01) 
and BTK arteries (HR = 1.9; 95% CI 1.2–3.2; p = 0.008) was 
found to be an independent predictor of the lack of clinical 
improvement accompanied by the need for reinterven-
tions. The ROC curves assessing the relationships between FC 
measured in the BTK arteries after PTA did not meet the study 
endpoints. Our attempts to determine the cut-off points for 
FC that best display the risk of poorer clinical outcomes failed. 
DISCUSSION 
During the previous decade, angioplasty and stent placement 
became an accepted, and in many situations, preferred al-
ternative to surgical treatment in patients with symptomatic 
limb ischaemia [1]. Despite their safety and effectiveness, the 
number of reinterventions related to endovascular procedures 
remains high. In the femoropopliteal region, restenosis rates 
in some groups of patients following endovascular procedures 
are described as higher than after a traditional bypass surgery 
[15]. Thus, improvement of patency is one of the major chal-
lenges for endovascular procedures.
In the past few years, many studies have been conducted 
focusing on factors that could influence the clinical outcome 
of endovascular treatment. Based on the BASIL study, factors 
that contributed to the survival model were age, presence 
of tissue loss, serum creatinine, ABI, prior myocardial infarc-
tion, history of stroke, body mass index, smoking status, 
and Bollinger angiogram score [2]. The FINNVASC and 
PREVENT III studies evaluated the post-procedural risk level 
based on variables such as age, tissue loss, coronary artery 
disease, diabetes mellitus, or dialysis [3]. It was confirmed 
that haemodialysis alongside cilostazol administration, stent 
fracture, and TASC lesion type were independent predictors 
of successful femoropopliteal stenting with nitinol stents [16]. 
Research performed among patients with end-stage kidney 
disease and their coronary arteries revealed a reduction in 
blood flow velocity assessed using the FC method [17]. Based 
on this, it was concluded that some comorbidities inducing 
decreased blood flow in the arteries could impact clinical 
outcomes following PTA of the peripheral arteries. There have 
been many reports stating that vessel runoff could be a strong 
predictor of clinical outcomes after endovascular treatment 
[7, 18, 19]. Conventionally, evaluation of vessel runoff has 
been estimated based on the Society for Vascular Surgery 
(SVS) runoff score or the number of patent tibial vessels [18]. 
The SVS runoff score was, in fact, an effective tool in predict-
ing treatment outcomes, but its complexity in the evaluation 
process made it too sophisticated for daily medical practice. 
There are some reports stating that the SVS runoff score was 
not reproducible among observers [20]. Based on the experi-
ence taken from interventional cardiology, the idea of using 
flow grades as a predictor of clinical outcomes in patients 
after endovascular procedures on the peripheral vessels was 
introduced. Hiramori et al. [6] evaluated the runoff grade by 
the final angiogram after endovascular therapy. Also, Davies et 
al. [7] proved that in patients presenting resting pain and tissue 
loss treated with endovascular techniques, patency was nega-
tively affected by compromised and poor runoffs. Although 
the runoff grade was shown to be an independent predictor 
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of endovascular treatment outcome, opinions were still based 
on the subjective evaluation of vessel blood flow, making it 
vulnerable to potential errors [21]. Therefore, in the current 
study, we aimed to investigate the relationship between the 
number of frames counted in the final angiogram and factors 
that may influence the clinical outcome after endovascular 
treatment. Statistically significant correlations have been 
found between the number of counted frames for the BTK 
arteries and age, Rutherford class, number of occluded BTK 
arteries, TASC classification, level of treated vessel, and the 
presence of critical limb ischaemia. Also, slower blood flow 
in the calf vessels was generally detected among the healthier 
population. Multiple studies have proven that improvement 
of clinical symptoms is related to the acceleration of periph-
eral blood flow after endovascular treatment compared to 
preoperative condition [22]. It has also already been stated 
that patients without significant blood flow after endovascular 
treatment have worse cumulative outcomes [6]. Salapura et 
al. [23] stated that faster blood flow after endovascular treat-
ment had better prognostic value only within the first month 
of observation. He found that clinical improvement in the 
12-month follow-up was significantly related to slower blood 
flow in the calf arteries. What is more, the lower FC (faster 
blood flow) predisposed to worse clinical outcomes after PTA. 
These finding were observed most significantly with regard to 
the anterior tibial artery, but the same phenomena were also 
present for TPA and FA. The current study demonstrated that 
PTA performed on the popliteal and BTK arteries is a prognos-
tic factor of poorer clinical outcomes during follow-up. This 
was not significantly related to the FC, despite the fact that 
the relationship between FC and the PTA level was initially 
observed. Furthermore, univariate analysis also showed such 
a relationship, which turned out to be statistically significant 
in the case of amputation, the lack of clinical improvement, 
and composite study endpoints. However, the relationship 
between FC, PTA, and clinical outcomes proved to be too 
weak to be confirmed using multivariate analysis. Based on 
magnetic resonance angiography, Prince et al. [24] found that 
female patients with type 2 diabetes mellitus and cellulitis or 
ulcerations on the legs tended to have faster blood flow in 
the lower limb arteries. It has been hypothesised that faster 
blood flow is a result of vascular calcifications and decreased 
arterial compliance, which forces faster flow velocity. More ad-
vanced clinical condition (higher Rutherford class) is frequently 
related to the presence of peripheral ulcers that can result in 
vasodilatation and increased demand for flow, thereby causing 
its acceleration. Another possible explanation for the presence 
of faster blood flow in patients with more advanced PAD is 
the fact that with peripheral vessel occlusions, the velocity 
of blood flow can be related to the smaller cross-sectional 
diameter of collateral vessels compared to the main arteries. It 
may also relate to distal ischaemia, which stimulates vasodila-
tion distal to occlusions. The FC technique presented in the 
current study is a simple and objective method created to 
predict clinical outcomes after endovascular procedures on 
the peripheral arteries.
The FC could be influenced by additional factors such as 
coronary perfusion pressure (including the severity of heart 
failure expressed as left ventricular ejection fraction), pressure 
of the contrast injection, vessel size, the length of lower limb 
arteries above the BTK arteries, the number of branches, ste-
nosis severity, heart rate (including atrial fibrillation), the use 
of certain medications, and other factors related to endothelial 
function and the coagulation system. 
In conclusion, the results suggest a negative relationship 
between FC observed on the final angiogram and clinical 
outcomes in patients undergoing endovascular treatment of 
the peripheral arteries. FC should be considered as a simple 
and effective index that can be used in the future to predict 
vessel patency in this group of patients. 
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WHAT IS NEW?
Several predictors of clinical outcomes after percutaneous interventions of the infrainguinal arteries have been demon-
strated. The status of blood flow velocity in below-the-knee arteries after intervention assessed by angiography has not 
been determined. The aim of the study was to investigate whether the dynamics of blood flow in the below-the-knee 
arteries correlate with clinical outcomes after a 12-month follow-up period in patients with severe leg ischaemia treated 
percutaneously. After the procedure, blood flow in all patent below-the-knee arteries was assessed using frame count. 
During the 12-month follow-up, clinical condition, as well as reintervention and amputation rates were observed. Patients 
with higher frame count in the tibial anterior artery experienced significantly better clinical improvement within the 
follow-up period. Lower frame count predisposed to worse clinical outcomes after angioplasty. The results suggest better 
clinical outcomes during the follow-up in patients with slower blood flow assessed by frame count after endovascular 
interventions of the infrainguinal arteries. 
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